PROVIDER PROFILE · NPI 1134111586

George Feinbaum

PRACTICEMANHATTAN MEDICAL BLDG.See all providers at this practice →

Internal MedicineBrooklyn, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

289

Unique beneficiaries

—

Total services

443

Distinct HCPCS

Medicare payment

$23K

Peer benchmark

Total Medicare services vs. 7,864 Internal Medicine providers in NY — below median (cohort median 552).

PRESCRIBING · PART D · 2024

Total Rx claims

4,044

Beneficiaries

—

Total drug cost

$405K

Distinct drugs

Brand share

25.5%

Top prescribed drugs

Lisinopril249 claims

Simvastatin245 claims

Atorvastatin Calcium206 claims

Amlodipine Besylate180 claims

Metformin Hcl180 claims

QUALITY · MIPS · 2024

Final MIPS score

90.8

Quality

91.8

Cost

75.2

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.66%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 330214

Hospital

REFERRAL NETWORK

Where George Feinbaum's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 3 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Shuja Qadir Cardiology · Brooklyn, NY	14	32

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Quest Diagnostics Incorporated Clinical Laboratory · Clifton, NJ	70	184
Gideon Yoeli Diagnostic Radiology · White Plains, NY	21	26
Robert Lerch Otolaryngology · Brooklyn, NY	15	53

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history